Blue Jet Healthcare Limited has informed the Exchange regarding a press release dated February 28, 2026, titled "Company Update".
BLUEJET · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Blue Jet Healthcare has performed the groundbreaking (Bhoomi Pujan) for its new manufacturing facility in Rambilli Cluster Phase II, Anakapalli District, Andhra Pradesh, on February 28, 2026. The Board of Directors had already approved Phase 1 of the project with an investment of approximately ₹1,000 crore via a resolution dated July 31, 2025. The Vizag plant is planned as a multi-phase development with long-term investment potential of up to ₹2,300 crore, subject to business milestones, regulatory approvals, and future Board clearances. The facility will focus on making complex pharmaceutical intermediates and active pharmaceutical ingredients (APIs), strengthening the company's position as a global supplier to pharmaceutical innovators. At full scale, the project is expected to create high-skilled direct jobs and contribute to the regional industrial ecosystem.
This is a significant capacity expansion announcement that signals long-term growth ambitions and a major capital outlay of up to ₹2,300 crore over time. Near-term, the ₹1,000 crore Phase 1 capex could pressure margins and free cash flows during the build-out phase, but successful execution should support future revenue growth and strengthen Blue Jet's position in the global pharma intermediates and API supply chain, which is a positive long-term signal for shareholders.